Ozempic May Cause Gallbladder or Intestinal Issues
If you or a loved one used Ozempic as a weight loss Drug and have had Gallbladder or Intestinal problems you may be entitled to Substantial Compensation.
If you or a loved one used Ozempic as a weight loss drug and have had Gallbladder or Intestinal problems you may be entitled to substantial compensation. Talk to an AVA Legal Expert today to understand all your options.
Semaglutide is an anti-diabetic and weight loss medication developed in 2012 by Novo Nordisk, commonly sold by the brand names Ozempic and Wegovy. This drug increases insulin secretion and blood sugar disposal by imitating the action of peptides that improve glycemic control. This drug also changes the appetite of individuals who take this drug by slowing down the process of emptying the stomach.
Since its FDA approval in 2017, Semaglutide has been prescribed for diabetes control and off-label weight loss purposes with once-weekly subcutaneous doses of Ozempic and Wegovy being used for weight management. Doctors generally only prescribe drugs for off-label use if all other drugs approved to treat a condition yield unsuccessful results. However, with the increased popularity of Semaglutide because of celebrity testimonials touting its success with cosmetic weight loss, Ozempic has become mainstream for doctors to prescribe it off-label for weight management.
SIDE EFFECTS OF OZEMPIC
With the continued use of this drug, recent studies have shown that diabetics taking Ozempic have reported serious complications of:
pancreatitis
acute kidney injuries
gallbladder disease
and intestinal blockages
Between 2018 and March 31st of 2023, more than 13,000 cases of adverse events related to the continued use of Ozempic have been reported to the FDA. Among those cases, 5,639 of them were reported to be serious, and 148 deaths have been attributed to the drug.
CONTACT OUR LEGAL TEAM FOR A FREE CASE EVALUATION
AVA LAW GROUP CAN HELP
CONNECT WITH OUR LEGAL TEAM TODAY
If you or a loved one used Ozempic as a weight loss drug and have had Gallbladder or Intestinal problems you may be entitled to substantial compensation. Talk to an AVA Legal Expert today to understand all your options.
In 2022, another FDA review of Ozempic revealed that the drug may be linked to acute cholecystitis, also known as acute gallbladder disease. 42% of individuals who developed gallbladder disease experienced the onset of the condition within 90 days of starting treatment with Ozempic. Gallbladder removal was necessary for the treatment of this condition, but three of these cases resulted in death. No warning was made by Novo Nordisk in regards to these gallbladder complications until March of 2022 when the study had already been conducted and released with the knowledge of the drugmaker.
LET’S LOOK AT THE LATEST STUDIES
In March of 2023, researchers released a study that found a significantly increased risk of intestinal obstruction with the continued use of Semaglutide, because the drug is known to reduce motility in the gut. The small intestine is primarily affected by these obstructions, becoming inelastic and fibrotic due to the change in gut motility which in turn causes obstructions. These obstructions are potentially fatal conditions that require surgery to prevent severe injury or death. In the study, type 2 diabetics were shown to be at a risk of 4.5 times higher than others who used other glucose control medications.
In addition to the potentially fatal risk of intestinal obstruction, Ozempic has been known in recent years to potentially cause fecal incontinence and/or constipation. Numerous individuals who have used the drug report said that they have passed stools in bed at night. Still, others have reported that they are uncomfortable with leaving their homes because they are afraid of experiencing an episode of fecal incontinence in public. In spite of these reports, Novo Nordisk has yet to place a warning or mention of this serious side effect that is linked to this drug.
We make walking through the legal process easy
Problem Solving is our promise
We provide a team of attorney, paralegals, and case managers to clients at no upfront cost.
AVA Law Group eliminates the confusion of filing a claim by working on your claim and, if necessary, connecting you with one our many partner firms that fits your needs and will get you the best results.
We’re available 24/7 to provide you with the information you need about case qualification.
Contact Us Today for your free, in-depth case evaluation
ATTORNEY ADVERTISEMENT: Not available in all states, Andrew Van Arsdale, supervising attorney is licensed only in California, District of Columbia, Montana, and Nevada, but associates with attorneys throughout the country, Principal office: 3667 Voltaire Street, San Diego, California 92106. AVA Law Group has associated with de Ondarza Simmons PLLC whose office is located at 4030 Wake Forest Road, Suite 319, Raleigh, North Carolina for all Camp Lejeune Cases in North Carolina.
Consult a doctor on all medical decisions. Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death. No representation is made that the quality of the legal services performed is greater than the quality of the legal services performed by other lawyers. AVA Law Group, Inc. not accepting cases in states where this advertising conflicts with laws or state rules. Legal representation is not offered or available in Tennessee. While AVA Law Group, Inc. maintains joint responsibility, most cases are referred to other attorneys for principal responsibility.
